10% Off
Ultivent-M150 mcg+50
Square Pharmaceuticals PLC.
৳585.00
Add to cart
Generic medicine
Indacaterol + Glycopyrronium + Mometasone Furoate: Brands, Price & Uses in Bangladesh
Indacaterol + Glycopyrronium + Mometasone Furoate is a fixed-dose triple combination inhaled therapy containing a long-acting beta2-agonist (LABA), a long-acting muscarinic antagonist (LAMA) and more.
About Indacaterol + Glycopyrronium + Mometasone Furoate
Indications of Indacaterol + Glycopyrronium + Mometasone Furoate
Indacaterol + Glycopyrronium + Mometasone Furoate is a fixed-dose triple combination inhaled therapy containing a long-acting beta2-agonist (LABA), a long-acting muscarinic antagonist (LAMA), and an inhaled corticosteroid (ICS), delivered once daily via a single dry-powder inhaler.
Established / Approved Use
- Maintenance treatment of asthma: Indacaterol + Glycopyrronium + Mometasone Furoate is indicated for the maintenance treatment of asthma in adult patients who are not adequately controlled on a maintenance combination of a long-acting beta2-agonist and a high-dose inhaled corticosteroid, and who have experienced one or more asthma exacerbations in the previous year.
Important Notes
- Indacaterol + Glycopyrronium + Mometasone Furoate is a maintenance (controller) therapy only and must be taken regularly, once daily, even when the patient feels well.
- Indacaterol + Glycopyrronium + Mometasone Furoate is not indicated for the initial or first-line treatment of asthma, and is not intended for patients whose asthma is controlled on lower-intensity therapy.
- Indacaterol + Glycopyrronium + Mometasone Furoate is not a rescue medication and must never be used for the relief of acute bronchospasm or an acute asthma attack; a separate short-acting bronchodilator must be available for such episodes.
- Indacaterol + Glycopyrronium + Mometasone Furoate is not indicated for chronic obstructive pulmonary disease (COPD) or other respiratory conditions outside its approved asthma indication.
Dosage & Administration of Indacaterol + Glycopyrronium + Mometasone Furoate
Adult Dose
| Indication | Dose |
|---|---|
| Maintenance treatment of asthma (adults inadequately controlled on ICS/LABA) | Contents of one inhalation capsule, inhaled once daily via the dedicated inhaler, at the same time each day, at the strength prescribed by the physician (the maximum recommended strength should not be exceeded) |
Pediatric Dose
Safety and efficacy of Indacaterol + Glycopyrronium + Mometasone Furoate have not been established in patients under 18 years of age; it is not recommended for use in children or adolescents (see Pediatric Use).
Renal Impairment
No dedicated dose adjustment is established; use with caution and routine monitoring in patients with severe renal impairment or end-stage renal disease (see Use in Special Populations).
Hepatic Impairment
Use with caution in patients with moderate to severe hepatic impairment, as systemic exposure to the components may be increased (see Use in Special Populations).
Administration Technique
Indacaterol + Glycopyrronium + Mometasone Furoate capsules must never be swallowed. Each capsule is loaded into the dedicated inhaler device immediately before use and its contents inhaled through the mouthpiece in a single deep, forceful inhalation. Capsules must be kept in their blister and removed only immediately before use. After inhalation, the patient should rinse the mouth with water and spit it out without swallowing, to reduce the risk of oral candidiasis and systemic absorption.
Side Effects of Indacaterol + Glycopyrronium + Mometasone Furoate
The following adverse effects have been reported with Indacaterol + Glycopyrronium + Mometasone Furoate:
Common
- Nasopharyngitis and upper respiratory tract infection
- Headache
- Oral or oropharyngeal candidiasis (thrush)
- Cough and dysphonia (hoarseness/voice changes)
- Urinary tract infection
- Tachycardia (fast heartbeat)
- Musculoskeletal pain
- Asthma exacerbation
Uncommon
- Hyperglycemia
- Dry mouth
- Rash and other hypersensitivity reactions
- Cataracts (with prolonged use)
- Dysuria and urinary retention
- Palpitations and other cardiac rhythm disturbances
Patients should seek prompt medical attention for worsening breathing difficulty immediately after a dose (paradoxical bronchospasm), chest pain, palpitations, visual disturbance, or any severe or persistent adverse effect while using Indacaterol + Glycopyrronium + Mometasone Furoate.
Contraindications of Indacaterol + Glycopyrronium + Mometasone Furoate
Indacaterol + Glycopyrronium + Mometasone Furoate is contraindicated in patients with a known hypersensitivity to indacaterol, glycopyrronium, mometasone furoate, or to any of the excipients of the formulation.
Frequently Asked Questions about Indacaterol + Glycopyrronium + Mometasone Furoate
What is Indacaterol + Glycopyrronium + Mometasone Furoate used for?
Indacaterol + Glycopyrronium + Mometasone Furoate is a once-daily, single-inhaler triple combination therapy used for the maintenance treatment of asthma in adults whose asthma is not adequately controlled on a combination of an inhaled corticosteroid and a long-acting beta2-agonist, and who have had one or more asthma exacerbations in the past year.
How should I take Indacaterol + Glycopyrronium + Mometasone Furoate?
Indacaterol + Glycopyrronium + Mometasone Furoate is inhaled once daily, at the same time each day, using its dedicated inhaler device. Load one capsule into the device immediately before use, inhale forcefully and deeply through the mouthpiece, and rinse your mouth with water afterward without swallowing. Never swallow the capsule.
Can I use Indacaterol + Glycopyrronium + Mometasone Furoate for a sudden asthma attack?
No. Indacaterol + Glycopyrronium + Mometasone Furoate is a maintenance (controller) therapy and does not work quickly enough to relieve a sudden asthma attack or acute shortness of breath. You must keep a separate fast-acting rescue inhaler on hand at all times for acute symptoms, and seek medical attention if a rescue inhaler does not relieve symptoms.
What are the main side effects of Indacaterol + Glycopyrronium + Mometasone Furoate?
Common side effects include throat irritation, oral thrush (a fungal infection in the mouth, reduced by rinsing your mouth after each dose), headache, cough, hoarseness, urinary tract infection, and a fast heartbeat. Tell your doctor right away if you have worsening breathing right after a dose, chest pain, palpitations, eye pain or visual disturbances, or difficulty urinating.
Is Indacaterol + Glycopyrronium + Mometasone Furoate safe during pregnancy or breastfeeding?
Information on Indacaterol + Glycopyrronium + Mometasone Furoate in pregnancy and breastfeeding is limited. It should be used in pregnancy only if clearly needed and if the benefit outweighs the potential risk to the baby, since uncontrolled asthma itself can also be harmful in pregnancy; consult your physician. A doctor should also be consulted before using Indacaterol + Glycopyrronium + Mometasone Furoate while breastfeeding.
Can I stop Indacaterol + Glycopyrronium + Mometasone Furoate suddenly if I feel better?
No. Indacaterol + Glycopyrronium + Mometasone Furoate should not be stopped or its dose reduced suddenly without your doctor's guidance, as this can cause your asthma to worsen. Any change in your treatment should be made gradually and under medical supervision.
Disclaimer
The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.